$WAT (Waters Corporation)

$WAT {{ '2015-07-28T12:06:20+0000' | timeago}} • Announcement

$WAT 2Q15 PR: Diluted EPS was $1.27, up 12.39% from $1.13 in 2Q14. YTD 2015 EPS was $2.41, up 23.59% from $1.95 YoverY. As of July 4, 2015, WAT had total assets of $4028.84MM vs. $3877.93MM at Dec. 31, 2014. Total liabilities were $2096.25MM at July 4, 2015 vs. $1983.27MM at Dec. 31, 2014. Gross profit was $286.03 vs. $279.95MM at 2Q14.

$WAT {{ '2017-06-22T14:22:15+0000' | timeago}} • Announcement

$WAT announced that Dr. Flemming Ornskov, CEO of Shire plc, has been elected to $WAT’s BoD, effective June 22, 2017.

$WAT {{ '2017-06-15T15:06:19+0000' | timeago}} • Announcement

Andrew Alliance and $WAT signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. $WAT will combine its existing Glycoworks RapiFluor-MS (RFMS) N-Glycan Kits with an Andrew pipetting robot.

$WAT {{ '2017-06-01T13:56:03+0000' | timeago}} • Announcement

RedShift BioAnalytics, Inc. announced the closing of a $11MM Series C Preferred Stock financing, co-led by Technology Venture Partners and $WAT. The Series C financing allows RedShift to accelerate the commercialization of its biotechnology instrument platform in 2017. RedShift also hired Jeffrey Zonderman as Chief Commercial Officer.

$WAT {{ '2017-04-25T12:37:03+0000' | timeago}} • Announcement

$WAT reported a rise in 1Q17 earnings driven by strong 8% sales growth from pharmaceutical market and 5% sales growth from the industrial market. Net income rose to $105.56MM or $1.31 per share from $94.05MM or $1.15 per share last year. Sales grew to $497.97MM from $475.25MM. Adjusted EPS increased to $1.46 from $1.26.

$WAT {{ '2017-01-24T12:19:50+0000' | timeago}} • Announcement

During 4Q16, $WAT's highest geographical growth came from Asia, which posted a 16% constant currency sales growth rate. While sales in the U.S. and Europe, in constant currency, grew 2% and 9% respectively during the quarter.

$WAT {{ '2017-01-24T12:14:12+0000' | timeago}} • Announcement

Analytical systems and software maker $WAT posted a 15.4% growth in its 4Q16 earnings. The company's net income increased to $174.3MM from $151MM during 4Q15. Diluted EPS rose 17% to $2.15 from $1.83 during 4Q15. Net sales increased 7% YoverY to $629MM from $587MM during the prior year period. Excluding items, $WAT earned $2.21 per share.

$WAT {{ '2016-12-08T16:28:45+0000' | timeago}} • Announcement

$WAT appointed Sherry Buck as its CFO and SVP, effective Jan. 9, 2017. Buck replaces Eugene Cassis, $WAT's CFO since February 2014, who will transition to a senior advisory role.

$WAT {{ '2016-10-25T18:32:35+0000' | timeago}} • Webcast

For 4Q16, $WAT expects constant currency sales growth of approx. 5%. GM is expected to be around 60%. Net interest expense is expected to be about $7MM and operating tax rate is expected to be 14%. Adjusted diluted EPS is expected to be $2.08-2.18. For 2016, $WAT expects reported sales growth of about 6% and adjusted diluted EPS of $6.48-6.58.

$WAT {{ '2016-10-25T18:25:56+0000' | timeago}} • Webcast

$WAT's cash and short-term investments totaled $2.7Bil and debt was about $1.8Bil, bringing the net cash position to $931MM. In 3Q16, the company repurchased 440,000 shares for $69MM. Free cash flow came in at $128MM in 3Q16.

$WAT {{ '2016-10-25T18:15:48+0000' | timeago}} • Webcast

$WAT saw sales growth of 4% in Waters Instruments in 3Q16. In the TA Instruments business, revenues were up 1%, with flat sales in instrument systems and 6% growth in service revenues. In Japan, sales from the Waters portfolio declined modestly at constant currency.  The performance of the TA business in Japan was flat.

$WAT {{ '2016-10-25T18:05:19+0000' | timeago}} • Webcast

$WAT said the global industrial sector, which includes sales to the material characterization, food, environmental and fine chemicals market, grew 1% in 3Q16. Global weakness from the chemical industry contributed to slower growth in the TA Instruments and Waters product lines. In food safety and food quality applications, sales grew 7%.

$WAT {{ '2016-10-25T11:52:14+0000' | timeago}} • Announcement

In 3Q16, $WAT saw sales growth of 16% in Asia, with strong demand from China. Sales in Europe fell by 3%, with stronger Western European results, offset by weaker demand from Eastern Europe. Sales in the US decreased by 1%, with pharmaceutical sector growth offset by weaker governmental and academic demand.

$WAT {{ '2016-10-25T11:49:35+0000' | timeago}} • Announcement

In 3Q16, $WAT posted a 13% sales growth from the bio/pharmaceutical market and 2% sales growth from the industrial market, offset by a 15% decline in sales within the governmental and academic markets. Recurring revenues, the combination of service and chemistry consumables, posted 8% sales growth, while instrument system sales grew approx. 3%.

$WAT {{ '2016-10-25T11:46:04+0000' | timeago}} • Announcement

Analytical instruments manufacturer $WAT reported an increase in 3Q16 earnings helped by higher sales. Net income was $124.8MM or $1.53 per share in 3Q16, an increase of 9% compared to 3Q15. Total sales grew 5% to $527MM versus last year.

$WAT {{ '2016-07-26T18:48:11+0000' | timeago}} • Webcast

$WAT said that on the product front, water sales were up 8%, while TA sales were up 10%. Geographically, US sales were up 5% in 2Q16, Europe was up 12%, Japan up 3% and sales in Asia outside of Japan was up 10%. $WAT's cash and short term investment totaled $2.6Bil and debt was about $1.8Bil, bringing the company to a net cash position of $843MM.

$WAT {{ '2016-07-26T18:28:32+0000' | timeago}} • Webcast

$WAT, which competes with $PKI and $TMO, said the company's pharmaceutical market led the way with 12% growth in 2Q16. The company saw good growth in its core small molecule QA/QC as well as in large molecule R&D oriented applications. On product line dynamics, instrument sales grew 7% with positive demand for core LC and bench top LC-MS platforms.

$WAT {{ '2016-07-26T12:35:10+0000' | timeago}} • Announcement

$WAT said results from the company's end markets in 2Q16 were driven by 12% sales growth from its bio/pharmaceutical market and 7% sales growth from its industrial market. Geographically, $WAT's Asia sales rose 9% while Europe increased by 12%. Sales in the U.S. rose by 5% in the quarter.

$WAT {{ '2016-07-26T12:30:16+0000' | timeago}} • Announcement

Analytical systems and software maker $WAT reported a higher quarterly profit, helped by increased demand from its bio/pharmaceutical and industrial end markets. The company reported 2Q16 earnings of $128.2MM, or $1.59 per share, compared with $105.7MM, or $1.28 per share a year ago. Revenue rose 8% to $537MM.

$WAT {{ '2016-06-07T18:52:15+0000' | timeago}} • SEC

$WAT said that 1Q16 effective tax rate was 11.8% vs. 15.3% for 1Q15. The slump in effective tax rate is attributed to a quarter-specific tax benefit associated with modifications to certain stock compensation awards. In addition, the income tax provision for 2015 included a quarter-specific tax provision related to a pending tax audit settlement.

$WAT {{ '2016-06-07T18:51:43+0000' | timeago}} • SEC

During 1Q16, $WAT's net cash provided by operating activities was $160MM vs. 1Q15, up $5MM mainly due to higher sales volumes and timing of payments to vendors & collection of receivables from customers. Within cash flows used in investing activities, CapEx related to property, plant, equipment & software capitalization were $25MM.

Recent Transcripts

BA (The Boeing Company)
Wednesday, July 26 2017 - 2:30pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, July 26 2017 - 12:30pm
IART (Integra LifeSciences Holdings Corporation)
Wednesday, July 26 2017 - 12:30pm
WAT (Waters Corporation)
Tuesday, July 25 2017 - 12:00pm
GE (General Electric Company)
Friday, July 21 2017 - 12:30pm
SNA (Snap-on Incorporated)
Thursday, July 20 2017 - 2:00pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
DHR (Danaher Corp.)
Thursday, July 20 2017 - 12:00pm
A (Agilent Technologies Inc.)
Monday, May 22 2017 - 8:30pm
VRML (Vermillion, Inc.)
Thursday, May 11 2017 - 12:30pm
COHR (Coherent Inc.)
Tuesday, May 9 2017 - 8:30pm
PKI (PerkinElmer Inc.)
Thursday, May 4 2017 - 9:00pm
FLDM (Fluidigm Corporation)
Thursday, May 4 2017 - 9:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
CBMX (CombiMatrix Corporation)
Thursday, May 4 2017 - 8:30pm
PSDV (pSivida Corp.)
Thursday, May 4 2017 - 8:30pm
GGB (Gerdau S.A.)
Thursday, May 4 2017 - 5:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
TSLA (Tesla, Inc.)
Wednesday, May 3 2017 - 9:30pm
TECH (Bio-Techne Corp.)
Tuesday, May 2 2017 - 1:00pm

AlphaGraphics you may like